Dr. Agarwal's Health Care Limited (BOM:544350)

India · Delayed Price · Currency is INR

471.40

+3.65 (0.78%)

At close: Jun 22, 2026

16.97% (1Y)

Market Cap	149.68B +39.9%
Revenue (ttm)	20.80B +21.6%
Net Income	1.33B +59.6%
EPS	4.18 +50.4%
Shares Out	n/a
PE Ratio	112.38
Forward PE	80.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,212
Open	467.40
Previous Close	467.75
Day's Range	463.00 - 473.00
52-Week Range	385.65 - 567.80
Beta	n/a
Analysts	Buy
Price Target	545.00 (+15.61%)
Earnings Date	Aug 3, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr... [Read more]

Industry Health Services

Founded 2010

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544350

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544350 stock is "Buy." The 12-month stock price target is ₹545.00, which is an increase of 15.61% from the latest price.

Price Target

₹545.00

(15.61% upside)

Analyst Consensus: Buy

Stock Forecasts